| Harsha Naik, | |
|
1545 Atlantic Ave, Brooklyn, NY 11213-1122 | |
| (718) 613-4000 | |
| Not Available |
| Full Name | Harsha Naik |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 23 Years |
| Location | 1545 Atlantic Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588934426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 051819 (Connecticut) | Primary |
| 207R00000X | Internal Medicine | 051819 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vitas Healthcare Corporation | Middlebury, CT | Hospice |
| Constellation Hospice | Orange, CT | Hospice |
| Bridgeport Hospital | Bridgeport, CT | Hospital |
| Carolton Chronic & Conv Hosp, | Fairfield, CT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
Parents are often the first to notice when their otherwise healthy infant slowly begins to develop a lopsided skull. Sometimes the change in head shape can look like a flattened section in the back of the skull, or off to one side if the baby prefers looking toward one direction. The incidence of head shape asymmetries has risen, likely related to the successful Back to Sleep campaign, which has saved countless infant lives since it was introduced in 1994 to prevent sudden infant death syndrome.
One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis.
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.
› Verified 8 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
Parents are often the first to notice when their otherwise healthy infant slowly begins to develop a lopsided skull. Sometimes the change in head shape can look like a flattened section in the back of the skull, or off to one side if the baby prefers looking toward one direction. The incidence of head shape asymmetries has risen, likely related to the successful Back to Sleep campaign, which has saved countless infant lives since it was introduced in 1994 to prevent sudden infant death syndrome.
One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis.
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harsha Naik, 1545 Atlantic Ave, Brooklyn, NY 11213-1122 Ph: (718) 613-4000 | Harsha Naik, 1545 Atlantic Ave, Brooklyn, NY 11213-1122 Ph: (718) 613-4000 |
News Archive
A protein whose primary role is in the embryonic development of kidneys may play a future role in treating kidney failure. Indiana University School of Medicine researchers have successfully treated acute kidney injury in laboratory experiments using cells that were genetically reprogrammed to produce the protein. The research suggests there could be a potential future treatment using such cells delivered intravenously instead of surgically.
Parents are often the first to notice when their otherwise healthy infant slowly begins to develop a lopsided skull. Sometimes the change in head shape can look like a flattened section in the back of the skull, or off to one side if the baby prefers looking toward one direction. The incidence of head shape asymmetries has risen, likely related to the successful Back to Sleep campaign, which has saved countless infant lives since it was introduced in 1994 to prevent sudden infant death syndrome.
One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis.
Mercator Therapeutics, the first biopharmaceutical company to systematically use in vivo phage display technology to develop novel cancer drugs and Pepscan Therapeutics, a world leader in protein mimicry technologies for improved therapeutic peptides and anti-GPCR antibodies, today announced a multi-program research collaboration. The companies will collaborate to optimize Mercator's 'Homing Peptides' using Pepscan's proprietary CLIPS technology.
› Verified 8 days ago
Dr. Alexander Usorov, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 447 Atlantic Ave, Brooklyn, NY 11217 Phone: 718-858-6300 | |
Dr. Marcellus Andre Walker, MD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 2094 Pitkin Ave, Brooklyn, NY 11207 Phone: 718-240-0516 Fax: 718-240-0564 | |
Lotus Ahmed, D.O Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 518 Mcdonald Ave, Brooklyn, NY 11218 Phone: 917-848-5432 Fax: 347-252-6754 | |
Mrs. Sophia Schwartzman, MD Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 2700 Ocean Avenue, Brooklyn, NY 11229 Phone: 518-587-1141 | |
Dr. Haitham M Ahmed, MD, MPH Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Pennsylvania Avenue, Brooklyn, NY 11207 Phone: 718-240-2000 Fax: 718-240-2260 | |
Yanjin Yang, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-3000 | |
Ashwad Afzal, M.D. Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 506 6th St, Brooklyn, NY 11215 Phone: 718-780-5246 |